Skip to main content

Table 2 Relationship between Ki67 and PIK3CA mutation status a

From: Relationship of PIK3CA mutation and pathway activity with antiproliferative response to aromatase inhibition

   WT/Mu
  n WT, median (IQR) Mu, median (IQR) P-value
Baseline Ki67 81 18.2 (56, 12.7 to 27.3) 12.5 (25, 5.7 to 21.0) 0.051
2-week Ki67 75 5.8 (52, 1.8 to 19.8) 3.1 (23, 1.0 to 7.2) 0.050
2-wk/pre-Ki67% 73 31.3 (50, 14.5 to 70.8) 23.1 (23, 11.6 to 44.2) 0.346
  1. aMu, Mutant; WT, Wild type.